Catalog - Data.gov

An official website of the United States government

Here’s how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

This site is currently in beta, and your feedback is helping shape its ongoing development.

Data
Metrics
Organizations
User Guide
Contact

Search datasets

Found 1 dataset matching "antipsychotic-drugs".

Federal
Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study)
- Organization: U.S. Department of Health & Human Services
- Updated: 2025-09-06
Background In order to compare the effectiveness of different antipsychotic drugs in the treatment of schizophrenia it is very important to evaluate subjective response and compliance in...
- html
Search relevance: 108.10 | Views last month: 2

Filter selections are applied on each click

Sort by

Filter by keyword
Start typing to see suggestions

Popular keywords:

Filter by organization
Start typing to select an organization

Popular organizations:

Organization types

Federal Government

City Government

State Government

County Government

University

Tribal

Non-Profit

Filter by Geography
Start typing to see suggestions

Spatial data options

All datasets

Geospatial only

Non-geospatial only

About
Open Government
Website Policies
PERFORMANCE.GOV
Data.gov on Github

Follow @GSA

data.gov

An official website of the GSA's Technology Transformation Services

About GSA
Accessibility statement
FOIA requests
No FEAR Act data
Office of the Inspector General
Performance reports
Privacy policy

Looking for U.S. government information and services?

Visit USA.gov

Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study)